scispace - formally typeset
G

Gereon R. Fink

Researcher at Forschungszentrum Jülich

Publications -  976
Citations -  67974

Gereon R. Fink is an academic researcher from Forschungszentrum Jülich. The author has contributed to research in topics: Medicine & Functional magnetic resonance imaging. The author has an hindex of 114, co-authored 867 publications receiving 60853 citations. Previous affiliations of Gereon R. Fink include University of Geneva & University of Hamburg.

Papers
More filters
Journal ArticleDOI

Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine

Garry Ceccon, +8 more
- 21 Jan 2020 - 
TL;DR: The observed findings suggest that the combination of gemcitabine plus nab-paclitaxel is potentially effective in affected cerebrospinal fluid of pancreatic carcinoma patients.
Journal ArticleDOI

VPS13D: One Family, Same Mutations, Two Phenotypes.

Jan Niklas Petry-Schmelzer, +6 more
- 05 May 2021 - 
TL;DR: Here, two siblings with compound heterozygous variants in VPS13D but a considerable divergent phenotype highlighting the difficulties of phenotype–genotype correlation in this rare disease are reported.
Journal ArticleDOI

Temporal activation patterns of lateralized cognitive and task control processes in the human brain

René Gobbelé, +6 more
- 01 Apr 2007 - 
TL;DR: The knowledge of the clinical picture and the typical electrophysiological features of PNHS are essential to rule out differential diagnoses like ALS and in autoimmune and paraneoplastic forms the therapy should be focused on the underlying disease, membrane stabilisation should be performed in idiopatic forms.
Journal ArticleDOI

Remarks on this special issue.

Gereon R. Fink, +3 more
- 01 Nov 2003 - 
Journal ArticleDOI

Brain Morphometry Associated With Response to Levodopa and Deep Brain Stimulation in Parkinson Disease.

Hannah Jergas, +7 more
- 01 Feb 2022 - 
TL;DR: In this paper , the association of gray matter brain atrophy patterns, as identified by voxel-based morphometry, with acute response to levodopa and subthalamic nucleus deep brain stimulation was analyzed.